Marimed (MRMD) Director David R. Allen Receives 192,308 RSUs

What Happened
David R. Allen, a director of Marimed Inc. (MRMD), was granted 192,308 restricted stock units (RSUs) on July 15, 2026 as payment for board fees. The RSUs vested immediately and converted one-for-one into 192,308 common shares. No cash was paid by the insider (grant price reported as $0.00); the Form 4 shows the RSU award, the conversion/exercise of the derivative, and the settlement that left no RSUs outstanding.

Key Details

• Transaction date(s): July 15, 2026; Form 4 filed July 17, 2026 (timely filing).
• Reported entries: A = grant/award of 192,308 RSUs; M = exercise/conversion of derivative (conversion to 192,308 common shares). All reported at $0.00.
• Shares acquired: 192,308 common shares via conversion of RSUs. No sale of common stock was reported.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes: F1 — RSUs convert one-for-one to common stock. F2 — RSUs were granted and vested upon grant; no RSUs remain outstanding.
• Remark: RSUs were granted in lieu of cash as partial payment for the reporting person’s director fees.

Context
This was a compensation-related award (director fees paid in RSUs) rather than an open-market purchase or a sale. Such grants are routine for non-employee directors and don’t necessarily signal a personal bullish or bearish view. The RSUs immediately vested and converted to shares — effectively a cash-in-kind payment — and the filing does not report any market sale of the resulting shares.